Determination of promising inhibitors for N-SH2 domain of SHP2 tyrosine phosphatase: an in silico study
Molecular Diversity · 2024
DOI: 10.1007/s11030-024-10880-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, 2024. Verfasst von Emel Başak Gencer Akçok und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Life and Natural Sciences, Abdullah Gül University, 38080, Kayseri, Türkiye. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 11, Molecular Docking Simulation, src Homology Domains, Molecular Dynamics Simulation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abdullah Gul University.
Abstract (Originalsprache)
There are many genes that produce proteins related to diseases and these proteins can be targeted with drugs as a potential therapeutic approach. Recent advancement in drug discovery techniques have created new opportunities for treating variety of diseases by targeting disease-related proteins. Structure-based drug discovery is a faster and more cost-effective approach than traditional methods. SHP2 phosphatase, encoded by the PTPN11 gene, has been the focus of much attention due to its involvement in many types of diseases. The biological function of SHP2 is enabled mostly by protein–protein interaction through its SH2 domains. In this study, we report the identification of a potential small molecule inhibitor for the N-SH2 domain of SHP2 by structure-based drug discovery approach. We utilized molecular docking studies, followed by molecular dynamics simulations and MM/PBSA calculations, to analyze compounds retrieved from the Broad's Drug Repurposing Hub and ZINC15 databases. We selected 10 hit compounds with the best docking scores from the libraries and examined their binding properties in the N-SH2 domain. We found that compound CID 60838 (Irinotecan) was the most suitable compound with a binding free energy value of − 64.45 kcal/mol and significant interactions with the target residues in the domain. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Faculty of Life and Natural Sciences, Abdullah Gül University, 38080, Kayseri, Türkiye.
- Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, 35340, Balçova, İzmir, Türkiye.
- Izmir Biomedicine and Genome Center (IBG), 35340, Balçova, İzmir, Türkiye.
- Department of Bioengineering, Faculty of Life and Natural Sciences, Abdullah Gül University, 38080, Kayseri, Türkiye. ismail.akcok@agu.edu.tr.
ORCID-Profile: İsmail Akçok
Förderung
- Abdullah Gul University
Zitieren
APA
Gencer Akçok, E. B., Güner, H., & Akçok, İ. (2024). Determination of promising inhibitors for N-SH2 domain of SHP2 tyrosine phosphatase: an in silico study. Molecular Diversity. https://doi.org/10.1007/s11030-024-10880-2
Vancouver
Gencer Akçok EB, Güner H, Akçok İ. Determination of promising inhibitors for N-SH2 domain of SHP2 tyrosine phosphatase: an in silico study. Molecular Diversity. 2024. doi:10.1007/s11030-024-10880-2
BibTeX
@article{GencerAkok2024,
author = {Gencer Akçok, Emel Başak and Güner, Hüseyin and Akçok, İsmail},
title = {Determination of promising inhibitors for N-SH2 domain of SHP2 tyrosine phosphatase: an in silico study},
journal = {Molecular Diversity},
year = {2024},
doi = {10.1007/s11030-024-10880-2}
}
EUVIMED